SCHEMBL22490329

SCHEMBL22490329

CCCc1nc2cc(Br)cnc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
PKM P14618 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
KDM4C Q9H3R0 1/20 0.39
KMT2A Q03164 1/20 0.38
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
ABL1 P00519 2/20 0.37
RET P07949 2/20 0.37
KDR P35968 2/20 0.37
CDK7 P50613 2/20 0.37
CDK5 Q00535 2/20 0.37
PRKAA1 Q13131 2/20 0.37
AURKB Q96GD4 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
DYRK1A Q13627 2/20 0.37
AURKA O14965 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2721703 0.87 GAA (0.41) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL855352 0.84 DYRK1A (0.37) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL5103470 0.80 DYRK1A (0.39) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL2971825 0.80 DYRK1A (0.39) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL7835407 0.80 TDP1 (0.39) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL13607868 0.80 KMT2A (0.46) ALDH1A1MAPTKMT2AABL1RET
SCHEMBL13607882 0.79 SMN1; SMN2 (0.38) KDM4EPKMALDH1A1LMNAMAPT
SCHEMBL13607778 0.79 RAB9A (0.51) ALDH1A1LMNAMAPTNTRK1GSK3B
SCHEMBL27709833 0.79 ABL1 (0.32) KDM4EPKMALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL2972038 0.79 BDKRB2 (0.35) KDM4EPKMALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198053-A1 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-4-METHYLBENZAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS RIPK2 INHIBITORS FOR TREATING E.G. AUTOIMMUNE DISEASES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-10-01 WO disclosed